SEC 13F Intelligence

Equitec Proprietary Markets, LLC / AMED

Equitec Proprietary Markets, LLC’s Amedisys Inc Position

Does Equitec Proprietary Markets, LLC own Amedisys Inc (AMED)? Not currently — the last reported position was 17.0K shares worth $2M in Q1 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$2M
Q1 2025
Shares
17.0K
% of Portfolio
+1.12%
Quarters Held
7
position exited

Position History AMED

Reported value by quarter
Q3 ’23: $1MQ3 ’23Q4 ’23: $1MQ4 ’23Q1 ’24: $1MQ1 ’24Q2 ’24: $1MQ2 ’24Q3 ’24: $1MQ3 ’24Q4 ’24: $544,740Q4 ’24Q1 ’25: $2MQ1 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202517.0K$2M+1.12%
Q4 20246.0K$544,740+0.53%
Q3 202410.5K$1M+0.86%
Q2 202412.0K$1M+1.40%
Q1 202415.6K$1M+0.88%
Q4 202315.1K$1M+1.06%
Q3 202314.3K$1M+0.33%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Equitec Proprietary Markets, LLC’s full portfolio or all institutional holders of AMED.